The reported statements, read against the company's own industry.
Financials view
Market Capitalization
931.94MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Revenue (TTM)
2.67BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Profit Margin
-39.20%
vs Medical Devices peers
Updated Oct 28, 2026
Beta
0.7830x
vs all stocks
Updated Oct 28, 2026
52-Week Change
-51.36%
vs all stocks
Updated Oct 28, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Market Capitalization
931.94MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Enterprise Value
3.89BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Forward P/E
9.65x
vs Medical Devices peers
Updated Oct 28, 2026
Price to Sales (TTM)
0.3531x
vs Medical Devices peers
Updated Oct 28, 2026
Price to Book (MRQ)
0.5299x
vs Medical Devices peers
Updated Oct 28, 2026
Enterprise to Revenue
1.46x
vs Medical Devices peers
Updated Oct 28, 2026
Enterprise to EBITDA
8.04x
vs Medical Devices peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 9.34×.Updated Oct 28, 2026
Gross Margin
43.26%
vs Medical Devices peers
Updated Oct 28, 2026
Profit Margin
-39.20%
vs Medical Devices peers
Updated Oct 28, 2026
Operating Margin
-2.09%
vs Medical Devices peers
Updated Oct 28, 2026
Return on Assets (TTM)
0.38%
vs Medical Devices peers
Updated Oct 28, 2026
Return on Equity (TTM)
-45.91%
vs Medical Devices peers
Updated Oct 28, 2026
Revenue (TTM)
2.67BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Revenue per Share (TTM)
39.27USDUpdated Oct 28, 2026
Quarterly Revenue Growth
2.80%
vs Medical Devices peers
Updated Oct 28, 2026
Gross Profit (TTM)
1.20BUSD
vs all stocks (USD)
Updated Oct 28, 2026
EBITDA (TTM)
417.10MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Net Income (TTM)
-1.05BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Quarterly Earnings Growth (YoY)
2.77%
vs Medical Devices peers
Updated Oct 28, 2026
Operating Cash Flow (TTM)
-57.20MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Oct 28, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Payout Ratio
0.00%
vs Medical Devices peers
Updated Oct 28, 2026
Revenue
2.73BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
1.46BUSDFY2025 · Dec 31, 2025
Gross Profit
1.27BUSDFY2025 · Dec 31, 2025
Operating Income
54.80MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-1.11BUSDFY2025 · Dec 31, 2025
Income Tax Expense
24.10MUSDFY2025 · Dec 31, 2025
Net Income
-1.13BUSDFY2025 · Dec 31, 2025
EBIT
-924.60MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
488.50MUSDFY2025 · Dec 31, 2025
Research & Development
186.20MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
746.30MUSDFY2025 · Dec 31, 2025
Other Operating Expenses
97.70MUSDFY2025 · Dec 31, 2025
Non-operating Interest Income
2.20MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
183.10MUSDFY2025 · Dec 31, 2025
EPS (Basic)
-16.69USDFY2025 · Dec 31, 2025
EPS (Diluted)
-16.69USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
67.80MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
67.80MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-1.13BUSDFY2025 · Dec 31, 2025
Operating Cash Flow
-770.50MUSDFY2025 · Dec 31, 2025
Free Cash Flow
-958.70MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
169.80MUSDFY2025 · Dec 31, 2025
Interest Paid
172.40MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-1.13BUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
442.00MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
6.30MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
45.90MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
900.00KUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-117.50MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
40.00MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-56.30MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-188.20MUSDFY2025 · Dec 31, 2025
Purchase of Investments
0.00USDFY2025 · Dec 31, 2025
Sale of Investments
0.00USDFY2025 · Dec 31, 2025
Other Investing Activity
-4.50MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-192.70MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
2.56BUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-2.41BUSDFY2025 · Dec 31, 2025
Net Short-term Debt Issuance
3.00MUSDFY2025 · Dec 31, 2025
Common Stock Repurchase
0.00USDFY2025 · Dec 31, 2025
Other Financing Charges
-5.40MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
155.80MUSDFY2025 · Dec 31, 2025
Shares Outstanding
68.30MSharesUpdated Oct 28, 2026
Float Shares
61.15MSharesUpdated Oct 28, 2026
Shares Short
14.95MSharesUpdated Oct 28, 2026
Short Ratio
11.10days
vs all stocks
Updated Oct 28, 2026
Short % of Shares Outstanding
29.73%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 21.89%.Updated Oct 28, 2026
% Held by Insiders
0.92%
vs all stocks
Updated Oct 28, 2026
% Held by Institutions
124.13%
vs all stocks
Updated Oct 28, 2026
Total Cash (MRQ)
123.40MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Total Cash per Share (MRQ)
1.80USDUpdated Oct 28, 2026
Total Debt (MRQ)
3.08BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Total Debt to Equity (MRQ)
1.73x
vs Medical Devices peers
Updated Oct 28, 2026
Current Ratio (MRQ)
1.39x
vs Medical Devices peers
Updated Oct 28, 2026
Book Value per Share (MRQ)
25.99USDUpdated Oct 28, 2026
Total Assets
5.77BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.45BUSDFY2025 · Dec 31, 2025
Total Liabilities
3.85BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
4.32BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
2.88BUSDFY2025 · Dec 31, 2025
Total Current Liabilities
966.10MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
169.80MUSDFY2025 · Dec 31, 2025
Accounts Receivable
417.00MUSDFY2025 · Dec 31, 2025
Inventory
577.60MUSDFY2025 · Dec 31, 2025
Accounts Payable
279.40MUSDFY2025 · Dec 31, 2025
Short-term Debt
207.60MUSDFY2025 · Dec 31, 2025
Deferred Revenue
37.80MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
164.30MUSDFY2025 · Dec 31, 2025
Long-term Debt
2.63BUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
166.40MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
100.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
-996.00MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.92BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
9.92USDUpdated Oct 28, 2026
52-Week High
35.58USDUpdated Oct 28, 2026
52-Week Change
-51.36%
vs all stocks
Updated Oct 28, 2026
Beta
0.7830x
vs all stocks
Updated Oct 28, 2026
50-Day MA
12.81USDUpdated Oct 28, 2026
200-Day MA
16.76USDUpdated Oct 28, 2026
Avg 10-Day Volume
2.16MSharesUpdated Oct 28, 2026
Avg 30-Day Volume
2.07MSharesUpdated Oct 28, 2026
Diluted EPS (TTM)
-15.39USDUpdated Oct 28, 2026
Other Income / Expense
-976.90MUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 1.39×, lower than 95% of its Medical Devices peers (median 3.82×)Significant
Current ratio: 1.39Industry median: 3.82Industry P5: 1.48Peers compared: 105
Price-to-book is 0.53×, lower than 95% of its Medical Devices peers (median 2.34×)Notable